LANZILLOTTA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.223
EU - Europa 458
AS - Asia 123
AF - Africa 7
SA - Sud America 6
Totale 1.817
Nazione #
US - Stati Uniti d'America 1.216
IT - Italia 346
IN - India 45
SG - Singapore 42
SE - Svezia 25
CN - Cina 24
FR - Francia 16
DE - Germania 12
FI - Finlandia 8
IE - Irlanda 8
CA - Canada 7
GB - Regno Unito 7
NL - Olanda 7
BG - Bulgaria 5
CH - Svizzera 4
RO - Romania 4
TG - Togo 4
UA - Ucraina 4
AR - Argentina 3
BE - Belgio 3
JP - Giappone 3
PT - Portogallo 3
TR - Turchia 3
CL - Cile 2
HK - Hong Kong 2
NG - Nigeria 2
PK - Pakistan 2
PL - Polonia 2
AT - Austria 1
BR - Brasile 1
EE - Estonia 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 1.817
Città #
Fairfield 222
Rome 126
Ashburn 109
Woodbridge 106
Chandler 92
Seattle 91
Cambridge 80
Wilmington 67
Houston 65
Ann Arbor 41
San Paolo di Civitate 30
New York 27
Princeton 27
Lawrence 24
Fasano 20
Singapore 19
Dearborn 17
Milan 15
Norwalk 15
Boston 13
Millbury 13
Plano 13
Palermo 12
San Diego 12
Beijing 10
Des Moines 8
Dublin 8
Chicago 6
Redwood City 6
Andover 5
Florence 5
Munich 5
Sofia 5
Casarano 4
Lanciano 4
Lomé 4
Salerno 4
St Louis 4
Alatri 3
Ariccia 3
Brussels 3
Casale Monferrato 3
Coimbra 3
Federal 3
Geneva 3
Guangzhou 3
Helsinki 3
Istanbul 3
London 3
Ottawa 3
Paris 3
San Mateo 3
Santa Cruz 3
Toronto 3
Abbiategrasso 2
Bühl 2
Falls Church 2
Hefei 2
Islamabad 2
Kunming 2
Las Vegas 2
Manerba del Garda 2
Mannheim 2
Nanjing 2
Naples 2
Phoenix 2
Rende 2
San Jose 2
Spoltore 2
Warsaw 2
Acton 1
Amsterdam 1
Ardea 1
Bangkok 1
Bremen 1
Budapest 1
Carrollton 1
Catania 1
Cervinara 1
Chongqing 1
Cosenza 1
Edinburgh 1
Ercolano 1
Falkenstein 1
Ferentino 1
Frankfurt am Main 1
Fremont 1
Giugliano In Campania 1
Haikou 1
Hortolândia 1
Jakarta 1
Lainate 1
Leawood 1
Los Angeles 1
Montreal 1
Monza 1
Muizenberg 1
Málaga 1
New Orleans 1
Noisy-le-grand 1
Totale 1.444
Nome #
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity 137
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 117
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome 108
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome 99
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype 96
Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach 96
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome 96
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 87
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection 87
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome 78
Cytosolic serine hydroxymethyltransferase controls lung adenocarcinoma cells migratory ability by modulating AMP kinase activity 77
Targeting mitochondria in Alzheimer disease: rationale and perspectives 75
High-fat diet leads to reduced protein o-glcnacylation and mitochondrial defects promoting the development of Alzheimer’s disease signatures 72
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome 66
Oxidative stress, protein modification and Alzheimer disease 63
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models 62
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome 58
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies 56
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention 52
Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies 48
Protein oxidative damage in UV-related skin cancer and dysplastic lesions contributes to neoplastic promotion and progression 46
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration 45
Proteomics study of peripheral blood mononuclear cells in down syndrome children 44
The GALA project. practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts 40
Dynamic changes of BVRA protein levels occur in response to insulin: a pilot study in humans 28
Stress responses in down syndrome neurodegeneration: State of the art and therapeutic molecules 28
Broad kinase inhibition mitigates early neuronal dysfunction in tauopathy 26
Biliverdin reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β 21
Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome 16
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model 11
Redox imbalance and metabolic defects in the context of Alzheimer disease 10
The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders 6
Totale 1.951
Categoria #
all - tutte 5.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020397 38 18 8 28 40 53 56 44 46 32 18 16
2020/2021320 15 13 8 10 12 16 21 22 32 117 38 16
2021/2022364 41 22 34 14 32 25 32 29 17 20 59 39
2022/2023342 45 71 12 39 30 39 11 22 29 13 21 10
2023/2024266 18 21 17 18 28 60 2 12 4 25 27 34
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 1.951